In medical news:

The FDA announced yesterday that boxed warnings on concurrent use of opioids with benzodiazepines or other drugs that depress the central nervous system will be added to the drugs’ labels, along with other information on the risks. According to MedPage Today, the announcement follows an FDA review of studies showing that using medications from both drug classes together – as well as combining opioids with alcohol and other agents that depress the central nervous system – has caused a variety of adverse effects including death. The review also found that these problems are becoming more prevalent.

Read more here.

Leave a Comment

Your email address will not be published. Required fields are marked *